SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company, today announced it has closed a non-brokered, ...
News
- bioAffinity Technologies Announces Closing of $5000000 Convertible Note Financing
- 'This is something we need,' COVID-19 vaccine trial to start in San Antonio
Biotech company, Moderna, is in a hurry to come up with a vaccine that will help make antibodies to fight COVID-19. Doctor Douglas Denham, Chief ...
- Local research center in race for COVID-19 vaccine
San Antonio — The race for a COVID vaccine has been at warp speed around the world for months. The TX Biomedical Research Institute here – is in ...
- Contractor Cements Client Partnerships
... for the South Texas Biomedical Research Institute, a San Antonio-based biomedical research firm engaged in efforts to combat the COVID-19 virus.
- Trump seeks political shot in the arm in vaccine push
President Donald Trump speaks during a coronavirus briefing at Bioprocess Innovation Center at Fujifilm Diosynth Biotechnologies, Monday, July 27, ...